CCL4 and malaria: The meta-analysis of two studies reporting MIP-1β levels in severe and uncomplicated malaria cases [33,34] revealed no significant difference in MIP-1β levels between severe malaria cases (n = 120) and uncomplicated malaria cases (n = 69) (p = 0.7943, random effects model, SMD: 0.1736, 95% CI: −1.1316 to 1.4788, I2: 93.9%, number of studies: two, 189 individuals, Figure 5).